72 related articles for article (PubMed ID: 3698034)
1. Role of tumor-associated macrophages in lung cancer.
Takeo S; Yasumoto K; Nagashima A; Nakahashi H; Sugimachi K; Nomoto K
Cancer Res; 1986 Jun; 46(6):3179-82. PubMed ID: 3698034
[TBL] [Abstract][Full Text] [Related]
2. Antitumor activity of macrophages in lung cancer patients with special reference to location of macrophages.
Nakahashi H; Yasumoto K; Nagashima A; Yaita H; Takeo S; Motohiro A; Furukawa T; Inokuchi K; Nomoto K
Cancer Res; 1984 Dec; 44(12 Pt 1):5906-9. PubMed ID: 6498848
[TBL] [Abstract][Full Text] [Related]
3. Role of antitumor activity of alveolar macrophages in lung cancer patients.
Kuda T; Yasumoto K; Yano T; Nakahashi H; Sugimachi K; Nomoto K
Cancer Res; 1987 Apr; 47(8):2199-202. PubMed ID: 3829005
[TBL] [Abstract][Full Text] [Related]
4. Border between N1 and N2 stations in lung carcinoma: lessons from lymph node metastatic patterns of lower lobe tumors.
Okada M; Sakamoto T; Yuki T; Mimura T; Nitanda H; Miyoshi K; Tsubota N
J Thorac Cardiovasc Surg; 2005 Apr; 129(4):825-30. PubMed ID: 15821650
[TBL] [Abstract][Full Text] [Related]
5. Role of skip metastasis to mediastinal lymph nodes in non-small cell lung cancer.
Prenzel KL; Mönig SP; Sinning JM; Baldus SE; Gutschow CA; Grass G; Schneider PM; Hölscher AH
J Surg Oncol; 2003 Apr; 82(4):256-60. PubMed ID: 12672010
[TBL] [Abstract][Full Text] [Related]
6. Relationships between tumor-associated macrophages and clinicopathological factors in patients with colorectal cancer.
Nakayama Y; Nagashima N; Minagawa N; Inoue Y; Katsuki T; Onitsuka K; Sako T; Hirata K; Nagata N; Itoh H
Anticancer Res; 2002; 22(6C):4291-6. PubMed ID: 12553072
[TBL] [Abstract][Full Text] [Related]
7. Skip mediastinal lymph node metastasis and lung cancer: a particular N2 subgroup with a better prognosis.
Riquet M; Assouad J; Bagan P; Foucault C; Le Pimpec Barthes F; Dujon A; Danel C
Ann Thorac Surg; 2005 Jan; 79(1):225-33. PubMed ID: 15620948
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of metastasis to the highest mediastinal lymph node in nonsmall cell lung cancer.
Sakao Y; Miyamoto H; Yamazaki A; Oh T; Fukai R; Shiomi K; Saito Y
Ann Thorac Surg; 2006 Jan; 81(1):292-7. PubMed ID: 16368383
[TBL] [Abstract][Full Text] [Related]
9. Immunocomplexes and primary lung cancer.
Lenzini L; Rottoli L; Sestini P; Carriero G; Sani G; Gotti G
Allergol Immunopathol (Madr); 1981; 9(2):119-22. PubMed ID: 6270995
[TBL] [Abstract][Full Text] [Related]
10. Antitumor activity of pleural cavity macrophages and its regulation by pleural cavity lymphocytes in patients with lung cancer.
Nagashima A; Yasumoto K; Nakahashi H; Takeo S; Yano T; Nomoto K
Cancer Res; 1987 Oct; 47(20):5497-500. PubMed ID: 3652051
[TBL] [Abstract][Full Text] [Related]
11. Predominant infiltration of macrophages and CD8(+) T Cells in cancer nests is a significant predictor of survival in stage IV nonsmall cell lung cancer.
Kawai O; Ishii G; Kubota K; Murata Y; Naito Y; Mizuno T; Aokage K; Saijo N; Nishiwaki Y; Gemma A; Kudoh S; Ochiai A
Cancer; 2008 Sep; 113(6):1387-95. PubMed ID: 18671239
[TBL] [Abstract][Full Text] [Related]
12. [Surgical treatment for stage III N2 non-small cell lung cancer].
Wang S; Wu Y; Rong T; Huang Z; Ou W
Zhonghua Zhong Liu Za Zhi; 2002 Nov; 24(6):605-7. PubMed ID: 12667337
[TBL] [Abstract][Full Text] [Related]
13. The significance of one-station N2 disease in the prognosis of patients with nonsmall-cell lung cancer.
Misthos P; Sepsas E; Kokotsakis J; Skottis I; Lioulias A
Ann Thorac Surg; 2008 Nov; 86(5):1626-30. PubMed ID: 19049761
[TBL] [Abstract][Full Text] [Related]
14. Extent of lymphadenectomy and outcome for patients with stage I nonsmall cell lung cancer.
Varlotto JM; Recht A; Nikolov M; Flickinger JC; Decamp MM
Cancer; 2009 Feb; 115(4):851-8. PubMed ID: 19140203
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of genetically diagnosed lymph node micrometastasis in non-small cell lung carcinoma cases.
Hashimoto T; Kobayashi Y; Ishikawa Y; Tsuchiya S; Okumura S; Nakagawa K; Tokuchi Y; Hayashi M; Nishida K; Hayashi S; Hayashi J; Tsuchiya E
Cancer Res; 2000 Nov; 60(22):6472-8. PubMed ID: 11103815
[TBL] [Abstract][Full Text] [Related]
16. TGF-beta receptor 2 downregulation in tumour-associated stroma worsens prognosis and high-grade tumours show more tumour-associated macrophages and lower TGF-beta1 expression in colon carcinoma: a retrospective study.
Bacman D; Merkel S; Croner R; Papadopoulos T; Brueckl W; Dimmler A
BMC Cancer; 2007 Aug; 7():156. PubMed ID: 17692120
[TBL] [Abstract][Full Text] [Related]
17. Postoperative radiotherapy for stage II or III non-small-cell lung cancer using the surveillance, epidemiology, and end results database.
Lally BE; Zelterman D; Colasanto JM; Haffty BG; Detterbeck FC; Wilson LD
J Clin Oncol; 2006 Jul; 24(19):2998-3006. PubMed ID: 16769986
[TBL] [Abstract][Full Text] [Related]
18. Lymph node isolated tumor cells and micrometastases in pathological stage I non-small cell lung cancer: prognostic significance.
Rena O; Carsana L; Cristina S; Papalia E; Massera F; Errico L; Bozzola C; Casadio C
Eur J Cardiothorac Surg; 2007 Dec; 32(6):863-7. PubMed ID: 17936004
[TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of surgical-pathologic multiple-station N1 disease in non-small cell carcinoma of the lung.
Sayar A; Turna A; Kiliçgün A; Solak O; Urer N; Gürses A
Eur J Cardiothorac Surg; 2004 Mar; 25(3):434-8. PubMed ID: 15019674
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of surgical-pathologic N1 disease in non-small cell carcinoma of the lung.
Riquet M; Manac'h D; Le Pimpec-Barthes F; Dujon A; Chehab A
Ann Thorac Surg; 1999 Jun; 67(6):1572-6. PubMed ID: 10391257
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
